The Marcus Center for Cellular Cures (MC3) is a joint initiative between Duke’s School of Medicine (SOM) and Pratt School of Engineering. The Center seeks to develop transformative clinical therapies using cells, tissues, molecules, genes, and biomaterials to treat diseases and injuries currently lacking effective treatment. The SOM and Pratt are partnering to support inter-institutional collaborative research teams.
This pilot program is designed to facilitate collaborative and novel translational research that applies or accelerates discovery into testing in clinical settings and/or optimizes current translational approaches. Projects must demonstrate stakeholder engagement and a high translational potential with a clear path for continued development to move into clinical practice or other applications via subsequent grant support, new company formation, licensing, not-for-profit partnering, or other channels.